Thermo Fisher Scientific Gibco CTS OpTmizer Pro Serum Free Media (SFM)

Wednesday, 10 February, 2021 | Supplied by: Thermo Fisher Scientific



Thermo Fisher Scientific has developed a medium for the development and expansion of human T lymphocytes (T cells) for cell therapy developers using allogeneic workflows. The Gibco CTS OpTmizer Pro Serum Free Media (SFM) is a media solution that targets the metabolism of healthy donor cells, making it suitable for use in the production of allogeneic, off-the-shelf cell therapies.

In contrast to autologous cell therapies, which are produced using a patient’s own cells, allogeneic cell therapies are derived from healthy donor tissue, potentially enabling more scalable cell therapy manufacturing. The SFM enhances donor T cell proliferation, maintains central memory T cells further into expansion and delays effector differentiation of healthy donor T cells, resulting in fast production of central memory cells.

The product packaging is suitable for closed systems and is manufactured in conformity with current Good Manufacturing Practice (cGMP) standards. The serum-free media is ready to use and compatible with automated and long workflows, providing a consistent formulation designed to maintain cell quality and increase the efficacy of cell-based therapies.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

GeneTex zebrafish antibodies

The antibodies have been tested on zebrafish samples in a variety of applications including, but...

Matreya LLC tocopherols

Matreya LLC scientists have developed high-purity tocopherol standards to advance antioxidant...

ORF Genetics ISOkine human recombinant leukaemia inhibitory factor (LIF)

ORF Genetics' ISOkine human recombinant LIF is a highly purified and endotoxin-free cytokine...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd